Home › Griffin Securities Reiterates $95.00 Price Target for Ligand Pharmaceuticals
 

Keywords :   


Griffin Securities Reiterates $95.00 Price Target for Ligand Pharmaceuticals

2014-09-27 08:07:22| Biotech - Topix.net

Griffin Securities' price objective points to a potential upside of 98.25% from the company's current price. A number of other firms have also recently commented on LGND.

Tags: price target securities griffin

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
04.10Should you tip even if the service wasn't worth it?
04.10Hurricane Kirk Graphics
04.10Hurricane Kirk Forecast Discussion Number 22
04.10Tropical Storm Leslie Forecast Discussion Number 10
04.10Hurricane Kirk Wind Speed Probabilities Number 22
04.10Hurricane Kirk Public Advisory Number 22
04.10Summary for Hurricane Kirk (AT2/AL122024)
04.10Tropical Storm Leslie Public Advisory Number 10
More »